RecruitingNCT06840717

Association Between Genetic Polymorphisms and Type 2 Asthma in Children

Association Between Cytokines Gene Single Nucleotide Polymorphisms and Type 2 Inflammatory Asthma in Children


Sponsor

Guangzhou Institute of Respiratory Disease

Enrollment

300 participants

Start Date

Jan 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

To further understand the role of gene single nucleotide polymorphism (SNP) in the occurrence of type 2 inflammation-related asthma in children by analyzing the gene single nucleotide polymorphism (SNP), lung function and type 2 inflammation indicators of children diagnosed with asthma in outpatient and inpatient. To provide a theoretical basis for the study of personalized treatment and prevention strategies for asthma.


Eligibility

Min Age: 3 YearsMax Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This study is examining whether certain gene variations affect how children respond to type 2 asthma treatments. By understanding these genetic differences, doctors may be able to better predict which medications will work best for individual children with asthma. **You may be eligible if...** - You are a child with a confirmed asthma diagnosis based on standard guidelines (GINA 2023) - Your doctor has ruled out other conditions that might cause similar symptoms - You have not taken antibiotics or systemic steroids in the 2 weeks before entering the study - You do not have other complications like congenital heart disease or pneumonia **You may NOT be eligible if...** - You have been taking immunosuppressants or antibiotics for a long time before coming to the hospital - You have primary immune deficiency - Your family is unwilling or unable to cooperate with the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Guangzhou institute of respiratory disease

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06840717


Related Trials